CR Medical (01515) Releases Updated Board and Committee Composition

Bulletin Express
03/11

China Resources Medical Holdings Company Limited (CR Medical, 01515) disclosed its latest board structure and committee memberships on 11 March 2026.

Board Composition • Total directors: 9 – Executive Directors: 4 (Yu Hai – Chairman; Zhang Chuang – Chief Executive Officer; Wang Yuexing; Wu Xinchun – Vice President) – Non-Executive Director: 1 (Fang Xin) – Independent Non-Executive Directors (INEDs): 4 (Wu Ting Yuk, Anthony; Fu Tingmei; Zhou Peng; Lo Wing Sze)

Committee Structure 1. Audit Committee • Chair: Fu Tingmei (INED) • Members: Wu Ting Yuk, Anthony (INED); Zhou Peng (INED); Fang Xin (NED)

2. Nomination Committee • Chair: Wu Ting Yuk, Anthony (INED) • Members: Yu Hai (Executive Director); Lo Wing Sze (INED)

3. Remuneration Committee • Chair: Yu Hai (Executive Director) • Members: Fu Tingmei (INED); Lo Wing Sze (INED)

Key Takeaways • Independent directors hold 4 of 9 board seats, underscoring compliance with Hong Kong governance requirements for board independence. • All three statutory committees are led by independent directors or the board chairman, aligning with best-practice standards for oversight and accountability.

The announcement did not indicate any changes to the existing board or committee memberships beyond the above disclosure.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10